Animal experiments have shown that albumin can counteract the decline in arterial vascular reactivity caused by endotoxemia, alleviate ischemia-reperfusion injury, and possess anti-inflammatory effects. The gene discussed is ALB; the disease is serum lipopolysaccharide activity.